Loading clinical trials...
Loading clinical trials...
Multi-center Double-blind Randomized Controlled Trial to Evaluate Effectiveness and Safety of Co-administered Traumeel® / Zeel® Intra-articular Injections vs Placebo in Patients With Moderate-to-Severe Pain With Osteoarthritis of the Knee
Conditions
Interventions
Traumeel® / Zeel® Injectable Solution
Placebo
Locations
30
United States
Clinical Research Advantage - Arizona II
Phoenix, Arizona, United States
Tucson Orthopaedic Institute
Tucson, Arizona, United States
Universal BioPharma Research Inc.
Dinuba, California, United States
Providence Clinical Research
North Hollywood, California, United States
Hans Richard Barthel, M.D., Inc.
Santa Barbara, California, United States
Westlake Medical Research
Westlake Village, California, United States
Start Date
June 1, 2013
Primary Completion Date
January 1, 2014
Completion Date
January 1, 2014
Last Updated
April 2, 2018
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Biologische Heilmittel Heel GmbH
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions